DMMC COURSES & WORKSHOPS

MOLECULES TO MEDICINES: HOW BIOPHARMA DELIVERS Lecture Course
Tue 9 May 2006
Venue: Lecture Theatre, UCD Conway Institute, University College Dublin (location)

Online application is closed
Online application period: 3 - 24 Apr 2006

This DMMC/Wyeth course will be of interest to research students, academic staff and clinicians, whether contemplating a career in industry or doing translational research in academia. The lectures will provide an overview of biopharmaceutical discovery, development and manufacturing.

Please apply early to ensure your place.

LECTURE COURSE: Tue 9 May; 0930-1700

0930 Overview of biopharmaceutical discovery to
         launch & course learning objectives
         Dr Brendan Hughes & Dr Seamas Donnelly
0950 Molecules to medicines: clinical perspective
         Dr Seamas Donnelly  abstract

DISCOVERY Dr Davinder Gill  abstract
1030 Introduction to the business of discovering
         biopharmaceuticals
1110 Coffee/Tea
1130 Current Biopharmaceutical product candidates
         and a look into next generation technologies

DEVELOPMENT Dr Mark Leonard  abstract
1210 Manufacturing cell line development
1250 Lunch break
1340 Process development and characterization

MANUFACTURING Dr Brendan Hughes  abstracts
1420 Introduction to the science and technology
         of biopharmaceutical manufacturing
1500 Coffee/Tea
1520 Focus on the application of molecular
         technologies in manufacturing environments

1600 Discussion & round up

Course Developers/Instructors comprise key personnel from Wyeth BioPharma and from the Department of Medicine & Therapeutics, St Vincent’s University Hospital & University College Dublin. Follow the links below to read short biographies.

Dr Brendan Hughes (Director of Development, Wyeth Medica Ireland, Grange Castle)
Dr Mark Leonard (Director, Gene Expression Technologies, Wyeth BioPharma Campus, Andover, MA, USA)
Dr Davinder Gill (Director, Antibody Technologies, Wyeth Research, Cambridge, MA, USA)
Dr Seamas Donnelly (Head of Medicine & Therapeutics (SVUH), University College Dublin)